Laman UtamaVX1 • ETR
add
Vertex Pharmaceuticals Incorporated
Tutup sebelumnya
€447.45
Julat tahun
€315.70 - €474.80
Permodalan pasaran
123.56B USD
Bilangan Purata
66.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2024info | Perubahan T/T |
|---|---|---|
Hasil | 2.65B | 6.11% |
Perbelanjaan pengendalian | 372.20J | 41.74% |
Pendapatan bersih | -3.59B | -492.44% |
Margin untung bersih | -135.83 | -469.81% |
Pendapatan bagi setiap syer | -12.83 | -429.82% |
EBITDA | 988.90J | -16.03% |
Kadar cukai berkesan | -5.97% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 5.80B | -48.42% |
Jumlah aset | 20.13B | -1.07% |
Jumlah liabiliti | 5.36B | 9.81% |
Jumlah ekuiti | 14.77B | — |
Syer tertunggak | 258.10J | — |
Harga kepada buku | 7.81 | — |
Pulangan pada aset | 10.61% | — |
Pulangan pada modal | 13.36% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -3.59B | -492.44% |
Tunai daripada operasi | -3.75B | -430.89% |
Tunai daripada pelaburan | -463.70J | -52.58% |
Tunai daripada pembiayaan | -358.60J | -2,172.83% |
Perubahan bersih dalam tunai | -4.58B | -633.74% |
Aliran tunai bebas | 629.82J | -39.74% |
Perihal
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
Diasaskan
1989
Ibu pejabat
Tapak web
Pekerja
5,400
